National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria (LuCaReAl)
Status
Conditions
Treatments
Details and patient eligibility
About
National, prospective, multicentric, non-interventional registry-based study, conducted among oncologists, pulmonologists in community and university hospitals, from the public sector in Algeria.
The study will collect information on the characteristics, and lung carcinomas patterns of patients whose lung cancer diagnosis was confirmed by a pathologist during the study period.
Full description
The study consists of:
- All patients meeting inclusion/exclusion criteria presenting to their oncologists/pulmonologists for a routine visit during recruitment period will be sequentially asked to participate to the study.
- The patients who do not consent will only be reported as new case of lung cancer for the incidence study.
The patients who consent to participate to the study will perform four in-hospital visits (Inclusion visit, visit at 3, 6 and 12 months). In addition to the 4 visits, a phone contact with the patients every 6 months at years 2,3, 4 and 5 will be done by the investigator or one of his/her authorised representative or the CRO or during a routine visit to the investigator, to check the patient's survival status.
THE STUDY DURATION 72 MONTHS
Enrollment
Sex
Volunteers
Inclusion criteria
-
Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist
- Aged at least18 years at diagnosis
- Patients who provide their informed consent form
Exclusion criteria
- Patients who did not provide the informed consent form
- Patients with a mental or psychological disorder according to their treating clinicians
Trial design
897 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal